Abstract
During the COVID-19 pandemic, much has been said about the importance of host-specific and virus-specific factors as predictors of the risk of infection and severity of disease. For example, host factors such as increased age, male gender, ethnicity, and comorbidities such as metabolic and pulmonary disorders have been recognized as risk factors for severe disease, whereas host immunity stemming from prior infection or vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with reduced severity. Similarly, the viral evolution of SARS-CoV-2 over the past 4 years has been scrutinized to estimate changes in the relative transmissibility, virulence and vaccine-match of each emerging variant over time during the COVID-19 pandemic. However, despite this scrutiny, variation in transmissibility and severity of disease remain imperfectly understood.
An aspect that has been comparatively ignored is the importance of transmission factors such as the size of viral inoculation and the duration of exposure, i.e., the dose of exposure. The dose of exposure is determined by human behavior, environmental conditions and mitigation strategies, such as indoor versus outdoor exposure, indoor crowding, indoor air ventilation and physical distancing. As observed for a range of pathogens, the risk of getting infected, and in some studies, also the disease severity and post infection sequelae depend on the dose encountered. We hypothesize that a quantitative exposure approach, where dose of exposure is included as a factor that determine important factors such as risk of infection, incubation period, outcome of infection and transmissibility, may be helpful for our understanding of the epidemiology of COVID-19. More importantly, if this hypothesis can be generalized across other pathogens, a quantitative exposure approach to infection epidemiology may open new options for mitigation of a future severe pandemic, Disease X, and point a way forward to a control strategy with a gentler impact on society.
Introduction: The Missing Piece of the Epidemiological Triad
Traditional epidemiological models often treat exposure as a binary state: a host is either exposed or unexposed. While this simplification is useful for basic transmission tracking, it fails to account for the biological reality of infectious diseases. This paper argues that the "infectious dose"—the initial quantity of pathogen a person is exposed to—is a critical determinant of disease severity and progression.
As illustrated in Figure 1, the outcome of an infection is not solely a product of the pathogen's virulence or the host's underlying health. Instead, it is the result of a complex interaction where transmission factors, specifically the dose-response relationship, play a pivotal role. By shifting toward a quantitative microbial risk assessment (QMRA) framework, researchers can better predict whether an exposure will lead to asymptomatic infection, symptomatic illness, or severe disease.
Evidence for Dose-Dependent Severity
The hypothesis that dose determines severity is supported by a wide range of historical and contemporary data across various pathogens:
- Incubation Periods: Higher initial doses are consistently linked to shorter incubation periods in diseases like cholera, HIV, and measles. A massive initial viral load can overwhelm innate immune barriers (such as mucus and early cellular responses) before the adaptive immune system has time to react.
- SARS-CoV-2 Observations: Recent household studies have correlated the duration of exposure and the viral load of the index case with both the risk of infection and the severity of the subsequent illness in secondary contacts.
- Historical Measles Data: In Danish studies, children infected at home by siblings (where exposure is typically prolonged and high-dose) exhibited significantly higher mortality rates compared to those infected outside the home.
- Salmonella and Human Challenge Studies: Controlled studies demonstrate clear dose-response curves where increasing the inoculum not only increases the probability of infection but also the severity of the clinical outcome.
The "Dilution Strategy" for Public Health
Recognizing the importance of infectious dose has profound implications for pandemic mitigation. If dose determines severity, then mitigation tools like masks, high-quality ventilation, and physical distancing do more than just prevent infection—they serve as "dilution" tools.
Even if a mask or a ventilation system does not block 100% of viral particles, reducing the inhaled dose may be sufficient to shift a patient's outcome from severe illness to a mild or asymptomatic case. This "dilution strategy" offers a path toward managing future pandemics with a gentler societal impact. Rather than relying on blunt measures like total lockdowns, public health efforts can focus on environmental engineering and behavioral changes that keep exposure doses below the threshold for severe disease.
Challenges and Future Directions
Transitioning to a quantitative exposure model presents several challenges. Measuring the exact dose received in real-world settings is technically difficult, and conducting human challenge studies for highly lethal pathogens involves significant ethical constraints. Furthermore, current population-level mathematical models are not yet fully equipped to handle exposure as a continuous variable.
Future work must focus on integrating QMRA into standard epidemiological frameworks. Mathematical biologists and public health officials should collaborate to develop models that account for dose-dependent outcomes, which will be essential for preparing for "Disease X" and ensuring that healthcare systems are not overwhelmed by high-dose, high-severity transmission events in crowded or poorly ventilated settings.
Summary updated